Technology advances, malaria-fighting efforts increase, and accurate and rapid diagnosis to treat diverse ailments are changing malaria diagnostics. Malaria RDTs are rising. Malaria may be detected quickly utilizing blood antigens in RDTs. This is consistent with worldwide malaria control objectives that aim to improve diagnosis, especially in resource-constrained locations with inadequate laboratory facilities.
Modern diagnostic technologies and their development are driving malaria diagnostics market growth. Nucleic acid amplification assays like polymerase chain reaction (PCR) are popular due to their great sensitivity and capacity to identify low-level infections. In malaria-endemic areas where asymptomatic infections are hard to detect, these emerging molecular diagnostic tools aid malaria diagnosis.
Malaria detection with digital technologies is growing. Digital platforms including mobile health (mHealth) apps and cloud-based solutions increase malaria data collecting, reporting, and monitoring. This trend meets the requirement for real-time data monitoring and makes malaria case tracking more efficient, improving public health interventions.
The malaria diagnostics industry is growing because to multiplexed tests. Multiplex testing can detect several malaria parasites and distinguish them from other febrile diseases. In areas with multiple malaria species, this accomplishment is significant. It lets doctors personalize malaria treatments to the organism that causes it.
Growing focus on point-of-care testing drives malaria diagnostics industry trends. Point-of-care diagnostics allow doctors to identify and treat patients quickly due to its speed and decentralization. This trend is especially strong in rural places with limited access to centralized labs. These places need timely identification to avert serious consequences and malaria transmission.
Due to the COVID-19 pandemic, malaria diagnostics emergencies have increased, highlighting the necessity for trustworthy diagnostic procedures in infectious disease management. The pandemic has shown the need of a strong diagnostic infrastructure for health emergencies. This tendency has led to increased expenditures in diagnostic capabilities, particularly malaria detection, to improve preparation and response to infectious threats.
Quality assurance and proficiency testing programs drive malaria diagnostics market expansion. Effective malaria prevention requires accurate and reliable diagnostic tests. Continuous efforts to establish and implement quality assurance standards, proficiency testing, and external quality evaluation programs increase malaria test diagnosis accuracy and confidence.
Clinical diagnostic corporations, research institutes, and public health authorities are collaborating to innovate malaria diagnoses. The combined initiatives aim to improve monitoring and reporting systems, increase diagnostic access in disease-endemic areas, and develop and test innovative diagnostic technologies. This movement promotes a global malaria eradication and diagnostics approach.
Fighting antimalarial medicine resistance is affecting malaria diagnostic breakthroughs. Diagnostic techniques help determine treatment choices and determine the incidence of resistant strains while monitoring drug resistance. Because of this tendency, constant monitoring with reliable diagnostic methods is more necessary than ever to guide evidence-based activities and ensure antimalarial treatment effectiveness.
Malaria diagnosis is advancing due to public-private collaborations and donor groups. Donor, NGO, and charity groups work with diagnostic firms to provide tests, educate staff, and support research and development. This trend improves healthcare infrastructure and availability to malaria-treating diagnostic technologies in malaria-endemic areas.
Report Attribute/Metric | Details |
---|
Malaria Diagnostics Market Segmentation
The malaria diagnostics market has been segmented on the basis of technology and end-user.
On the basis of technology, the market has been classified as rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics tests are segmented into polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR).
On the basis of end-users, the market has been classified as hospitals, clinics, community healthcare, and others.
On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.
The European malaria diagnostics market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.Â
The malaria diagnostics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The malaria diagnostics market in the Middle East and Africa has been segmented into the Middle East and Africa.Â
Regional Market Summary
Global Malaria Diagnostics Share, by Region, 2017 (%)
Source: MRFR Analysis
In the malaria diagnostics market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. In 2016, global governments of malaria-endemic countries have invested USD 2.7 billion in malaria control and elimination efforts. The US was the largest contributor by providing USD 1 billion for the eradication of malaria.
The European market is expected to hold the least share due to the growing number of malaria-free countries in the region.
The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism. The Asia-Pacific remains to be the second largest burden of malaria globally with 22 malaria-endemic countries accounting for roughly 28 million cases and 45,000 deaths every year. The WHO figures say that in the Asia-Pacific region, Myanmar, Pakistan, India, and Indonesia carry the highest malaria burden accounting for 89% of all malaria cases in the region.
The market in the Middle East and Africa is expected to account for the smallest share of the global malaria diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities. Sub-Saharan Africa remains to bring an excessively high share of the global malaria burden on the Middle Eastern and African market. the region was home to 90% of malaria incidences and 92% of malaria deaths in 2015
Malaria Diagnostics Market Key Players
Some of the key players in the global malaria diagnostics market are Access Bio. Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd, Sysmex Partec GmbH, bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation, and Bio-Rad Laboratories Inc.Recent Development
Global Malaria Diagnostics Market, by Technique
Global Malaria Diagnostics Market, by End-Users
Global Malaria Diagnostics Market, by Region
Americas
Europe
Asia-Pacific
Middle East & Africa
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)